| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |